Related Experiment Videos
Cholesterol and coronary heart disease. The 21st century
1Department of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, USA.
Insights
Lowering low-density lipoprotein (LDL) cholesterol significantly reduces coronary heart disease risk. Comprehensive management including other risk factors and preventive healthcare is crucial for further progress.
Area of Science:
- Cardiovascular Medicine
- Preventive Cardiology
- Lipid Metabolism
Background:
- High serum low-density lipoprotein (LDL) levels are a critical factor in atherosclerosis.
- Clinical trials confirm that reducing LDL cholesterol substantially decreases coronary heart disease (CHD) risk.
- Aggressive LDL lowering in high-risk patients offers significant reduction in CHD morbidity and mortality.
Purpose of the Study:
- To highlight the impact of LDL reduction on coronary heart disease.
- To emphasize the need for comprehensive strategies beyond LDL lowering for CHD prevention.
- To advocate for healthcare system reorganization towards prevention.
Main Methods:
- Review of recent clinical trial data on LDL cholesterol reduction.
- Analysis of evidence linking LDL levels to atherogenesis.
- Evaluation of additional risk factors and preventive measures.
Main Results:
- Substantial decrease in coronary heart disease risk demonstrated by LDL-lowering therapies.
- Confirmation of LDL as a key atherogenic factor.
- Significant potential for reducing CHD morbidity and mortality through aggressive LDL lowering.
Conclusions:
- While LDL lowering is crucial, controlling other risk factors like smoking, hypertension, and diabetes is essential for maximum benefit.
- Reorganization of healthcare delivery emphasizing prevention is necessary.
- Continued research is vital to eliminate coronary heart disease as a major cause of death.
Abstract:
Recent clinical trials have demonstrated that reductions of serum low-density lipoprotein (LDL) levels substantially decrease the risk for coronary heart disease. These trials confirm other lines of evidence that high levels of LDL are a critical atherogenic factor. Aggressive lowering of LDL levels in high-risk patients promises to significantly reduce morbidity and mortality from coronary heart disease in the first third of the 21st century. However, several additional measures will be required to marginalize coronary heart disease in the 21st century. Other lipoprotein abnormalities and other risk factors, eg, cigarette smoking, hypertension, and diabetes mellitus, must be controlled to obtain the full benefit of LDL-lowering therapy. Moreover, the health care delivery system must be reorganized to put more emphasis on prevention. Although much can be achieved through application of current knowledge in prevention efforts, further advances through new research will be required to remove coronary heart disease as a major cause of death in the United States.